JNJ Jan 2025 250.000 put
| Previous Close | 84.82 |
| Open | 85.57 |
| Bid | 84.45 |
| Ask | 86.20 |
| Strike | 250.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 85.56 - 85.57 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 3 |
Business WireJohnson & Johnson to Host Investor Conference Call on Third-Quarter Results
NEW BRUNSWICK, N.J., September 05, 2024--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 15th to review third-quarter results. Joaquin Duato, Chairman and Chief Executive Officer, Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson & Johnson’s e
ZacksInvestors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know
Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
ReutersJohnson & Johnson adds $1.1 billion to proposed talc settlement
(Reuters) -Johnson & Johnson plans to pay an additional $1.1 billion to resolve tens of thousands of legal actions alleging its baby powder and other talc products caused cancer, two people familiar with the matter said. The increase would boost the size of the settlement to more than $9 billion paid over 25 years. J&J on Wednesday said it reached an agreement with a plaintiffs' lawyer representing 12,000 clients to recommend the settlement offer to them, adding to support already received from other claimants.
